Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion

Clinical trial NCT02429726 · UNKNOWN

Trial details

NCT number: NCT02429726
Sponsor: Shenzhen SiBiono GeneTech Co.,Ltd
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Pleural Effusion

Start date: 2015-06-01
Primary completion: 2017-06-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.